Invention Grant
- Patent Title: Multivalent regulatory T cell modulators
-
Application No.: US16655544Application Date: 2019-10-17
-
Publication No.: US11059877B2Publication Date: 2021-07-13
- Inventor: Jeffrey Greve , Jungmin Kim , Niranjana Nagarajan , John Cho
- Applicant: Delinia, Inc.
- Applicant Address: US CA Emeryville
- Assignee: Delinia, Inc.
- Current Assignee: Delinia, Inc.
- Current Assignee Address: US CA Emeryville
- Agency: McCarter & English, LLP
- Main IPC: A61K38/20
- IPC: A61K38/20 ; C07K14/55 ; C07K14/54 ; C07K16/28 ; A61P29/00 ; A61P21/00 ; A61P37/06 ; A61P1/00 ; A61P17/06 ; A61P3/10 ; A61P25/28 ; A61P17/14 ; A61P17/00 ; C12N15/09 ; C07K19/00 ; A61K38/00
Abstract:
This disclosure provides compounds that contain an IL-2 receptor-binding moiety and an ST2-binding moiety. The methods described in the present disclosure provide for a method for treating a condition by administering to a subject in need thereof a therapeutically-effective amount of a compound containing an IL-2 receptor-binding moiety and an ST2-binding moiety.
Public/Granted literature
- US20200031897A1 MULTIVALENT REGULATORY T CELL MODULATORS Public/Granted day:2020-01-30
Information query
IPC分类:
